CXCR4 is highly produced in more than 20 tumor types, promoting tumor growth and progression, tumor invasiveness, and metastasis. That is what studies in lab-grown cells have shown. But a novel PET/CT imaging agent targeting CXCR4 in cancer mouse models and patients has shown otherwise. {read more here}